Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
This study has been completed.
Sponsor:
Progen Pharmaceuticals
Collaborators:
Northern Sydney and Central Coast Area Health Service
Aventis Pharmaceuticals
Information provided by:
Progen Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00268593
First received: December 20, 2005
Last updated: June 13, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | February 2008 |
| Primary Completion Date: | February 2008 (Final data collection date for primary outcome measure) |